tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geoff Meacham, 124 are a HOLD (31.63%), 238 are a BUY (60.71%), 30 are a SELL (7.65%).
Analyst Geoff Meacham, currently employed at CITI, carries an average stock price target met ratio of 58.84% that have a potential upside of 30.48% achieved within 233 days. Previously, Geoff Meacham worked at BAML.
Geoff Meacham’s has documented 773 price targets and ratings displayed on 59 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on MRNA, Moderna at 22-Oct-2025.
Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 7/28/2025. The price target of $50 was fulfilled within 2 days with a profit of $5.66 (12.76%) receiving and performance score of 63.82.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$205
$22.5 (12.33%)
4 years 5 months 27 days ago
(04-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold
$173
$-9.5 (-5.21%)
$156
4 years 5 months 29 days ago
(02-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
$190
4 years 6 months 6 days ago
(25-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Buy
$175
$-7.5 (-4.11%)
$165
4 years 8 months 28 days ago
(03-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Hold
$166
$-16.5 (-9.04%)
$175
4 years 8 months 28 days ago
(03-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
Which stock is Geoff Meacham is most bullish on?
Which stock is Geoff Meacham is most reserved on?
What Year was the first public recommendation made by Geoff Meacham?
